Meridian Bioscience Inc.

Meridian Bioscience Inc., a foreign-owned manufacturer of in vitro diagnostic test kits, reagents, and diagnostic instruments headquartered in Cincinnati, Ohio, operates exclusively as a prime contractor to federal healthcare agencies, supplying point-of-care diagnostics, breath analysis systems, and laboratory reagents without set-aside designations across a diverse customer base of 33 federal agencies.

Meridian competes in the full-and-open market with no SBA certifications. The company's capability portfolio centers on diagnostic testing equipment and consumables: H. pylori stool antigen assays and automated analyzers, BREATH ID Smart Systems for breath analysis and substance abuse screening, I-STAT blood analyzers for point-of-care testing, urea breath ID identification kits, laboratory reagents, and associated extended warranty and technical support services. Representative prime work includes a $310,583 definitive contract awarded by Veterans Integrated Service Network 22 on January 10, 2025, for 260 boxes of Meridian BreathID Kit Hp Two with five-year option periods and one-year base term (ultimate completion January 9, 2030); a $931,985 single-award BPA from the Indian Health Service awarded June 13, 2024, for BREATH ID Smart Systems, supplies, and extended warranty through June 16, 2029; and a $162,698.70 single-award BPA from Veterans Integrated Service Network 22 awarded September 23, 2024, for H. pylori stool antigen assays and automated analyzer with supplies supporting the VA Phoenix Healthcare System through February 22, 2030.

Customer concentration is diffuse across defense and civilian health agencies. The top five customers by combined potential value—Department of the Army Medical Command ($2 million across 19 awards), Department of the Air Force Materiel Command ($2 million across 9 awards), Department of Health and Human Services Indian Health Service ($1.5 million across 10 awards), Veterans Integrated Service Network 22 ($613 thousand across 6 awards), and Defense Health Agency ($572 thousand across 3 awards)—account for approximately 30% of Meridian's combined potential value across all awards. The discrepancy between award count concentration (top 5 customers represent 5% of the 1,452 total awards) and dollar concentration signals a high volume of small purchase orders alongside several anchoring BPAs. Meridian works with multiple Veterans Integrated Service Network regional commands and supports military medical facilities at Fort Hood, Texas and domestic VA healthcare systems across Phoenix, Loma Linda, and the Cincinnati area.

Meridian holds a position on five named Blanket Purchase Agreements: BPA FA860114A0001 carries 5 task orders and $421 thousand combined potential value; BPA FA860117A0021 carries 4 task orders and $384 thousand combined potential value; BPA 75H71224A00011 carries 3 task orders and $544 thousand combined potential value; BPA HHSI241200709327B carries 3 task orders; and BPA 36C26224A0031 carries 1 task order and $30 thousand combined potential value. These are agency-specific or network-specific agreements rather than government-wide vehicles.

Meridian's federal footprint remains modest in scale but stable. Total awards across all federal sources number 1,452 with combined potential value of $22.5 million and obligated dollars of $16.3 million (72% of potential value). Recent activity shows minimal volume: 1 award in 2026, 3 in 2025, 5 in 2024, and 5 in 2023, indicating a mature, low-velocity customer relationship without growth trajectory. Only 3 awards (combined potential value $302 thousand) reach ultimate completion within the next 24 months, presenting limited near-term recompete exposure.

Meridian's named subsidiaries include Bioline USA Inc., Magellan Diagnostics Inc., OEM Concepts Incorporated, Biodesign International Inc., and Meridian Life Science Inc., with Magellan Diagnostics and Meridian Life Science also carrying foreign-owned designations. The company's primary NAICS concentration sits on In-Vitro Diagnostic Substance Manufacturing (87 awards) and its PSC footprint is dominated by In Vitro Diagnostic Substances, Reagents, Test Kits And Sets (604 awards) and Laboratory Equipment and Supplies (576 awards), reflecting the core diagnostic consumables and equipment supply mission.